Holly Cuneo

Holly Cuneo has extensive work experience in the finance and operations field. Holly is currently serving as the Vice President, Head of Operations Finance at Vir Biotechnology, Inc. since July 2023. Prior to that, they worked at Sangamo Therapeutics, Inc. as the Vice President of FP&A and Treasury from July 2020 to June 2023.

Before their role at Sangamo Therapeutics, Inc., Holly held two positions at Gilead Sciences. Holly was the Sr. Director of Finance - FP&A from September 2019 to July 2020, and the Director of Corporate FP&A from May 2017 to August 2019.

Holly also worked as the Director of Finance at Leiter's from March 2015 to May 2017. Prior to that, they had multiple roles at Stryker Endoscopy, including Senior Financial Planning & Analysis Manager, Financial Planning & Analysis Manager, Market Research Manager, Financial Accounting Manager (Sales Operations), Accounts Payable Supervisor, and Financial Analyst.

Holly'scareer began at Triage Consulting Group, where they worked as an Associate Consultant from June 2005 to June 2006.

Holly Cuneo obtained a Bachelor of Science degree in Management Science from UC San Diego in 2005. Holly then pursued an M.B.A. degree at the University of California, Berkeley, Haas School of Business from 2009 to 2012.